Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-07-20

FDA Approved: INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 — Supplemental Application (Novo Nordisk Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental NDA for Novo Nordisk's Insulin Aspart Protamine and Insulin Aspart Mix 70/30, approving the supplement to the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 (insulin aspart protamine and insulin aspart mix 70/30)

Snippet

SUPPL AP for INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 (INSULIN ASPART)